These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11476752)

  • 1. Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure.
    Maki T; Nasa Y; Yamaguchi F; Yoshida H; Mori M; Takada T; Horikawa E; Okano K; Takeo S
    Cardiovasc Res; 2001 Aug; 51(3):608-17. PubMed ID: 11476752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation.
    Maki T; Nasa Y; Tanonaka K; Takahashi M; Takeo S
    J Pharmacol Exp Ther; 2003 Apr; 305(1):97-105. PubMed ID: 12649357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M; Hirth-Dietrich C; Stasch JP
    Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
    Chen HH; Lainchbury JG; Harty GJ; Burnett JC
    Circulation; 2002 Feb; 105(8):999-1003. PubMed ID: 11864932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of renal neutral endopeptidase in severe heart failure.
    Knecht M; Pagel I; Langenickel T; Philipp S; Scheuermann-Freestone M; Willnow T; Bruemmer D; Graf K; Dietz R; Willenbrock R
    Life Sci; 2002 Oct; 71(23):2701-12. PubMed ID: 12383878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
    Seymour AA; Abboa-Offei BE; Smith PL; Mathers PD; Asaad MM; Rogers WL
    Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):63-9. PubMed ID: 7768036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts.
    Maki T; Horio T; Yoshihara F; Suga S; Takeo S; Matsuo H; Kangawa K
    Br J Pharmacol; 2000 Nov; 131(6):1204-10. PubMed ID: 11082129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide.
    Walther T; Stepan H; Pankow K; Becker M; Schultheiss HP; Siems WE
    Biol Chem; 2004 Feb; 385(2):179-84. PubMed ID: 15101560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.
    Maeda K; Tsutamoto T; Wada A; Hisanaga T; Kinoshita M
    Am Heart J; 1998 May; 135(5 Pt 1):825-32. PubMed ID: 9588412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.
    Chen HH; Schirger JA; Chau WL; Jougasaki M; Lisy O; Redfield MM; Barclay PT; Burnett JC
    Circulation; 1999 Dec; 100(24):2443-8. PubMed ID: 10595958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure.
    Maki T; Nasa Y; Tanonaka K; Takahashi M; Takeo S
    Mol Cell Biochem; 2003 Dec; 254(1-2):265-73. PubMed ID: 14674706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting cardiac regional responses of A-type and B-type natriuretic peptide to experimental chronic heart failure.
    Hystad ME; Klinge R; Spurkland A; Attramadal H; Hall C
    Scand J Clin Lab Invest; 2000 Jul; 60(4):299-309. PubMed ID: 10943600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
    Chen HH; Burnett JC
    Proc Assoc Am Physicians; 1999; 111(5):406-16. PubMed ID: 10519161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy.
    Díez J
    Eur J Heart Fail; 2017 Feb; 19(2):167-176. PubMed ID: 27766748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
    Margulies KB; Barclay PL; Burnett JC
    Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of atrial natriuretic peptide and brain natriuretic peptide in atrial granules of rats with experimental congestive heart failure.
    Bialik GM; Abassi ZA; Hammel I; Winaver J; Lewinson D
    J Histochem Cytochem; 2001 Oct; 49(10):1293-300. PubMed ID: 11561014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition.
    Mellin V; Jeng AY; Monteil C; Renet S; Henry JP; Thuillez C; Mulder P
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):390-7. PubMed ID: 16116347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
    Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
    Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
    Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.